Key result
In mice, short-term administration of pravastatin partially reduced chronic vascular injury after irradiation, whereas long-term administration for one year completely reversed the irradiation-induced changes in vascular reactivity.
Why the study?
Statin use during radiation therapy has been associated with reduced cardiovascular risk, but whether irradiation causes chronic vascular injury and whether short-term statins are sufficient to prevent it compared with long-term statins remains unclear.
Does pravastatin prevent chronic vascular injury in mice exposed to head-and-neck irradiation?
Does pravastatin prevent chronic vascular injury in mice exposed to head-and-neck irradiation?
Answers are grounded in this paper and cite their sources.
In a mouse model, short-term pravastatin administration reduces, and long-term administration abolishes, chronic vascular injury and endothelial dysfunction one year after head-and-neck irradiation.
Background The incidental use of statins during radiation therapy has been associated with a reduced long-term risk of developing atherosclerotic cardiovascular disease. Objectives Determine if irradiation causes chronic vascular injury and whether short-term administration of statins during and after irradiation is sufficient to prevent chronic injury compared to long-term administration. Methods C57Bl/6 mice were pretreated with pravastatin for 72 hours and then exposed to 12 Gy x-ray head-and-neck irradiation. Subsequently, they received pravastatin either for one additional day or for one year. Carotid arteries were tested for vascular reactivity and altered gene expression one year after irradiation. Results Treatment with pravastatin for 24 hours reduced the loss of endothelium-dependent vasorelaxation and protected against enhanced vasoconstriction after IR. It reduced the expression of some markers associated with inflammation and oxidative stress and modulated that of subunits of the voltage and Ca 2+ activated K + (BK) channel in the carotid artery one year after irradiation. Treatment with pravastatin for one year completely reversed the changes caused by irradiation. Conclusions In mice, short-term administration of pravastatin is sufficient to reduce chronic vascular injury after irradiation. Long-term administration eliminates the effects of irradiation. These findings suggest that a prospective treatment strategy involving statins could be effective in patients undergoing radiation therapy. The optimal duration of treatment in humans has yet to be determined.
No takes yet. Share an insight, caveat, or question.
Ait‐Aissa et al. (2023) studied Radiation-induced vascular injury. Pravastatin vs. Vehicle was evaluated on Vascular reactivity (endothelium-dependent vasorelaxation and vasoconstriction) of carotid arteries one year after irradiation. In mice, short-term administration of pravastatin partially reduced chronic vascular injury after irradiation, whereas long-term administration for one year completely reversed the irradiation-induced changes in vascular reactivity.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: